These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 8396626

  • 1. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
    Rumpianesi F, Morandotti G, Sperning R, Satta G, Cevenini R.
    J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
    [Abstract] [Full Text] [Related]

  • 2. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D, Robbins MJ, Sanghrajka M, Leakey A, Ridgway GL.
    Drugs Exp Clin Res; 1991 Jun; 17(2):91-9. PubMed ID: 1650694
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
    Kilic D, Basar MM, Kaygusuz S, Yilmaz E, Basar H, Batislam E.
    Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of clindamycin against strains of Chlamydia trachomatis, Mycoplasma hominis, and Ureaplasma urealyticum isolated from pregnant women.
    Harrison HR, Riggin RM, Alexander ER, Weinstein L.
    Am J Obstet Gynecol; 1984 Jul 01; 149(5):477-80. PubMed ID: 6742014
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H, Bébéar C.
    Eur J Clin Microbiol Infect Dis; 1990 Nov 01; 9(11):838-41. PubMed ID: 1964899
    [Abstract] [Full Text] [Related]

  • 6. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M, Hallander HO.
    Scand J Infect Dis Suppl; 1988 Nov 01; 53():12-7. PubMed ID: 2843982
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH, Wagenvoort JH, van Klingeren B, Piot P, Stolz E, Michel MF.
    Eur J Clin Microbiol; 1986 Oct 01; 5(5):498-501. PubMed ID: 3096726
    [Abstract] [Full Text] [Related]

  • 8. [Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility].
    Zhou Y, Xu XL, Wang CP, Zhou M, Zeng XH.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun 01; 25(3):201-4. PubMed ID: 21977592
    [Abstract] [Full Text] [Related]

  • 9. In-vitro antimycoplasmal activity of flurithromycin.
    Furneri PM, Bisignano G, Cerniglia G, Tempera G, Nicoletti G.
    J Antimicrob Chemother; 1995 Jan 01; 35(1):161-5. PubMed ID: 7768764
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013.
    Wang QY, Li RH, Zheng LQ, Shang XH.
    J Microbiol Immunol Infect; 2016 Jun 01; 49(3):359-62. PubMed ID: 25081985
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
    Busolo F, Conventi L.
    Eur J Clin Microbiol Infect Dis; 1988 Jun 01; 7(3):407-10. PubMed ID: 3137045
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
    Lefèvre JC, Bauriaud R, Gaubert E, Escaffre MC, Lareng MB.
    Chemotherapy; 1992 Jun 01; 38(5):303-7. PubMed ID: 1337506
    [Abstract] [Full Text] [Related]

  • 13. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
    Waites KB, Duffy LB, Schmid T, Crabb D, Pate MS, Cassell GH.
    Antimicrob Agents Chemother; 1991 Jun 01; 35(6):1181-5. PubMed ID: 1929260
    [Abstract] [Full Text] [Related]

  • 14. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
    Waites KB, Cassell GH, Canupp KC, Fernandes PB.
    Antimicrob Agents Chemother; 1988 Oct 01; 32(10):1500-2. PubMed ID: 2973283
    [Abstract] [Full Text] [Related]

  • 15. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
    Farkas B, Ostorházi E, Pónyai K, Tóth B, Adlan E, Párducz L, Marschalkó M, Kárpáti S, Rozgonyi F.
    Orv Hetil; 2011 Oct 16; 152(42):1698-702. PubMed ID: 21979223
    [Abstract] [Full Text] [Related]

  • 16. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 2001 Sep 16; 45(9):2604-8. PubMed ID: 11502536
    [Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
    Welsh LE, Gaydos CA, Quinn TC.
    Antimicrob Agents Chemother; 1992 Feb 16; 36(2):291-4. PubMed ID: 1318677
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of the infection status and the drug resistance of mycoplasma and chlamydiae in genitourinary tracts of children with suspected nongonococcal urethritis].
    Wang Y, Yang WB, Yuan HY, Zhang QX, Zhu XY.
    Zhonghua Er Ke Za Zhi; 2009 Jan 16; 47(1):62-4. PubMed ID: 19573386
    [Abstract] [Full Text] [Related]

  • 19. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z, Rosenberg S, Dan M.
    J Chemother; 2011 Apr 16; 23(2):77-9. PubMed ID: 21571622
    [Abstract] [Full Text] [Related]

  • 20. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 1994 Nov 16; 38(11):2628-32. PubMed ID: 7872759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.